Owner Celltech R & D, Inc.

Inventors Kung Sutherland, May S; Yu, Changpu; Latham, John; Geoghegan, James C

Agent Davies Collison Cave

Pub. Number AU-B-2003223214

PCT Number PCT/US03/06193

PCT Pub. Number WO2003/073991

Priority 60/406,171 27.08.02 US; 60/447,393 13.02.03 US; 60/361,258 01.03.02 US

Filing date 28 February 2003

Wipo publication date 16 September 2003

Acceptance publication date 18 September 2008

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61K 31/5575 (2006.01)

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/573 (2006.01)

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/40 (2006.01) Medicinal preparations containing peptides - Transferrins, e.g. lactoferrins, ovotransferrins

A61P 19/10 (2006.01) Drugs for skeletal disorders

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/04 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine